Canada to Announce Approval of Moderna Vaccine for Omicron Variant on Thursday

Reuters Staff

September 01, 2022

WASHINGTON (Reuters) - Health Canada will announce Thursday that it has approved Moderna Inc's vaccine to fight the Omicron variant of the coronavirus, CBC News reported on Wednesday, citing sources.

Both Pfizer Inc and Moderna filed applications for vaccine approval and the Moderna vaccine approval will be formally announced on Thursday, the report added.

(Reporting by Kanishka Singh in Washington; Editing by Chris Reese)


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.